We are only able to display limited information for this firm. We display more complete information for all of the following firms:
A&O Shearman demonstrates capabilities in both life sciences and tech patents and has a strong track record in all major litigation venues. The team is particularly strong on Hatch-Waxman on both the brand and generic side. The team is led by New York’s Elizabeth Holland, a first-chair trial lawyer sought after by pharma, biotech and medical device companies. In Boston, John Bennett specializes in Hatch-Waxman and BPCIA cases. William James, in Washington DC, is another key Hatch-Waxman specialist who also focuses on IPR and appellate proceedings.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The A&O Shearman team is nothing but excellent. Very knowledgeable about our industry and the law, always available, providing practical no-nonsense advice.’
‘Tom (Thomas) Makin is outstanding. He is always available, excellent understanding of our industry, situation and how to navigate.’
Key clients
- University of Pennsylvania
- Alcon
Work highlights
- Advised University of Pennsylvania in a patent infringement litigation asserting its U.S. Patent No. 7,625,558 (methods of treating cancer tumors) against Genentech's multi-billion dollar products Herceptin, Perjeta, and Phesgo.
- Advised Alcon in the District of Delaware against Padagis Israel Pharmaceuticals Ltd., Padgis US LLC, and Padagis LLC (“Padagis”).